Deutscher Schmerzkongress 2022
zur Liste
Dr. Eric Albessard
Germany
  • Vortrag Efficacy of Fremanezumab in Migraine Patients With Pain or Psychiatric Comorbidities and Documented Inadequate Response to 2-4 Prior Migraine Preventive Medication Classes Speaker
    Datum: 21.10.2022 , Zeit: 12:00 | Thema: 18. Sonstiges
    Details
  • Vortrag Real-World Effectiveness of Fremanezumab in Patients with Refractory Migraine from a US Tertiary Headache Center who Switched from Erenumab Speaker
    Datum: 21.10.2022 , Zeit: 12:00 | Thema: 18. Sonstiges
    Details
  • Vortrag Consecutive Migraine-free Days with Fremanezumab Treatment: Results of the Double-blind, Placebo-controlled FOCUS Study Speaker
    Datum: 21.10.2022 , Zeit: 12:00 | Thema: 18. Sonstiges
    Details